The Trades Confirm the Diagnosis. They Don't Treat It.
The number that should be haunting Kyle Dubas this offseason isn't found in the standings, though 14.5 games back is damning enough. It's the production gap on the Pittsburgh blue line: Chase Pietila, the second defenseman on the depth chart, contributed essentially nothing behind Erik Karlsson this season. Not a down year, not a sophomore slump — nothing registerable. That's the structural wound the Hallander-for-Stastney swap and the Jones-and-Laatsch-for-Johnson deal were quietly stitching around. And the stitching, however competent, doesn't close the wound.
To be clear about what these trades represent: they are a front office acknowledging, in transaction form, that the defensive depth was inadequate. That acknowledgment is overdue and correct. Karlsson logged 23.7 minutes a night across 46 games, and Letang wasn't far behind at 22.0. Two aging defensemen carrying that kind of load on a team that was simultaneously hemorrhaging forwards to injury is not a sustainable construction — it's a structural bet that both men stay healthy and elite, which is a bet you lose eventually. The trades were Pittsburgh trying to hedge that bet mid-cycle.
The problem is that hedging a structural bet with personnel shuffles is not the same as fixing the structure. The depth chart behind Karlsson remains, by any honest read, threadbare. Pietila and Jake Livanavage are the names behind him. Whatever Stastney and Johnson bring, the grounding reality is unchanged: there is a massive production gap between the top pair and everyone beneath it, and no trade of this scale bridges that gap. You don't solve a foundation problem with spackle.
What makes this particularly frustrating is that the defensive improvement at the end of the season — Pittsburgh allowed 3.0 goals per game over the final 10 contests, down from 4.2 per game in the prior 20 — suggests the roster's foundational structure actually held when the lineup stabilized. That's a real finding. It means this isn't a broken system; it's an undermanned one. The bones are there. The bodies aren't. And adding Stastney and Johnson to a depth chart that was already showing structural promise in its final stretch tells you the front office sees the same thing — but the scale of the response doesn't match the scale of the problem.
My read is this: Dubas has correctly diagnosed the illness and prescribed the right category of medicine. Defensive depth, not just defensive stars. Bodies who can absorb minutes so Karlsson and Letang aren't running on fumes by February. That's the right instinct. But the dosage is wrong. The Penguins enter next season with a 40-year-old Malkin, a Crosby window that is narrowing by the month, and a blue line that still collapses the moment Karlsson misses a game. Two trades that move peripheral pieces for depth defensemen are an acknowledgment of the problem, not a solution to it. The box score on this offseason, so far, reads: diagnosis confirmed, treatment insufficient.